首页> 美国卫生研究院文献>Experimental Animals >A New Coronary Retroinfusion Technique in theRat Infarct Model: TransjugularCardiac Vein Catheterization
【2h】

A New Coronary Retroinfusion Technique in theRat Infarct Model: TransjugularCardiac Vein Catheterization

机译:大鼠梗死模型冠状动脉回输新技术:经颈静脉心脏静脉导管插入术

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cell delivery via the retrograde coronary route boasts less vessel embolism, myocardial injury, and arrhythmogenicity when compared with those via antegrade coronary administration or myocardial injection. However, conventional insertion into the coronary sinus and consequent bleeding complication prevent its application in small animals. To overcome the complication of bleeding, we described a modified coronary retroinfusion technique via the jugular vein route in rats with myocardial infarction (MI). A flexible wire with a bent end was inserted into the left internal jugular vein and advanced slowly along the left superior vena cava. Under direct vision, the wire was run into the left cardiac vein by rotating the wire and changing the position of its tip. A fine tube was then advanced along the wire to the left cardiac vein. This modified technique showed less lethal hemorrhage than the conventional technique. Retroinfusion via transjugular catheter enabled efficient fluid or cell dissemination to the majority areas of the free wall of the left ventricle, covering the infarcted anterior wall. In conclusion, transjugular cardiac vein catheterization may make retrocoronary infusion a more safe and practical route for delivering cell, drug, and gene therapy into the infarcted myocardium of rats.
机译:与通过顺行冠状动脉给药或心肌注射相比,通过逆行冠状动脉途径的细胞递送具有较少的血管栓塞,心肌损伤和心律失常性。然而,常规插入冠状窦和随之而来的出血并发症阻止了其在小型动物中的应用。为了克服出血的并发症,我们描述了一种通过颈静脉途径对患有心肌梗塞(MI)的大鼠进行改良的冠状动脉回输技术。将具有弯曲端的柔性线插入左颈内静脉,并沿着左上腔静脉缓慢前进。在直视下,通过旋转导线并改变其尖端位置将导线插入左心静脉。然后将一根细管沿导线推进到左心静脉。与常规技术相比,该改良技术显示出更少的致命性出血。通过经颈静脉导管进行的逆向输注能够有效地将液体或细胞散布到左心室游离壁的大部分区域,覆盖梗死前壁。总之,经颈静脉导管插入术可能使冠状动脉后输注成为将细胞,药物和基因疗法输送到大鼠梗塞心肌的更安全实用的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号